中國鐵塔(00788.HK)首三季利潤逾45.6億人幣 按年增17.8%
中國鐵塔(00788.HK)公布,今年首三季營業收入為602.2億元人民幣(下同),按年增長5.6%;EBITDA為440.19億元,按年上升5.4%;利潤為45.64億元,按年增長17.8%。
期內,塔類業務收入為547.98億元,按年增長2.2%;室內分佈式天線系統業務收入為26.34億元,按年增長36.9%;跨行業站址應用與信息及能源經營業務收入為26.12億元,按年增長92.8%。
集團首三季共建成5G站址34.5萬個,97%以上5G需求是通過共享已有站址資源完成。於今年9月30日,塔類站址數目為202萬個,較去年底增長1.3%;塔類租戶為333.6萬戶,增近3%。(ek/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.